Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme
Public ClinicalTrials.gov record NCT00458601. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to evaluate the clinical activity of CDX-110 vaccination when given with standard of care treatment (maintenance temozolomide therapy). Study treatment will be given until disease progression and patients will be followed for long-term survival information. Efficacy will be measured by the progression-free survival status at 5.5 months from the date of first dose.
Study identification
- NCT ID
- NCT00458601
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 82 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2007 (Type not available)
- Primary completion
- Nov 2010 (Actual)
- Completion
- May 2016 (Actual)
- Last update posted
- Jan 16, 2018
2007 – 2016
United States locations
- U.S. sites
- 34
- U.S. states
- 15
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Celldex Investigational Site | Orange | California | 92868 | — |
| Celldex Investigational Site | San Francisco | California | 94143-0622 | — |
| Celldex Investigational Site | San Francisco | California | 94143 | — |
| Celldex Investigational Site | Stanford | California | 94305-5826 | — |
| Celldex Investigational Site | Stanford | California | 94305 | — |
| Celldex Investigational Site | New Haven | Connecticut | 06510 | — |
| Celldex Investigational Site | New Haven | Connecticut | 06519 | — |
| Celldex Investigational Site | New Haven | Connecticut | 06520 | — |
| Celldex Investigational Site | Gainesville | Florida | 32610-0277 | — |
| Celldex Investigational Site | Chicago | Illinois | 60611 | — |
| Celldex Investigational Site | Evanston | Illinois | 60201 | — |
| Celldex Investigational Site | Boston | Massachusetts | 02115 | — |
| Celldex Investigational Site | Lansing | Michigan | 48912 | — |
| Celldex Investigational Site | Saginaw | Michigan | 48601 | — |
| Celldex Investigational Site | Saginaw | Michigan | 48604 | — |
| Celldex Investigational Site | Hackensack | New Jersey | 07601 | — |
| Celldex Investigational Site | Amherst | New York | 14226 | — |
| Celldex Investigational Site | New York | New York | 10032 | — |
| Celldex Investigational Site | New York | New York | 10065 | — |
| Celldex Investigational Site | Durham | North Carolina | 27710 | — |
| Celldex Investigational Site | Cincinnati | Ohio | 45219 | — |
| Celldex Investigational Site | Cincinnati | Ohio | 45267-0502 | — |
| Celldex Investigational Site | Cincinnati | Ohio | 45267-0769 | — |
| Celldex Investigational Site | Cleveland | Ohio | 44106 | — |
| Celldex Investigational Site | Cleveland | Ohio | 44195 | — |
| Celldex Investigational Site | Orange | Ohio | 44122 | — |
| Celldex Investigational Site | West Chester | Ohio | 45069-6542 | — |
| Celldex Investigational Site | Westlake | Ohio | 44145 | — |
| Celldex Investigational Site | Philadelphia | Pennsylvania | 19104 | — |
| Celldex Investigational Site | Houston | Texas | 77030 | — |
| Celldex Investigational Site | San Antonio | Texas | 78229 | — |
| Celldex Investigational Site | Salt Lake City | Utah | 84112 | — |
| Celldex Investigational Site | Charlottesville | Virginia | 22908 | — |
| Celldex Investigational Site | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00458601, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 16, 2018 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00458601 live on ClinicalTrials.gov.